Search for a trial | Research with human participants

2 results

Varenicline, a partial nicotinic receptor agonist, for the treatment of excessive daytime sleepiness in Parkinson*s disease: a placebo-controlled cross-over study

Approved WMORecruitment stopped

This study is aimed to determine the efficacy of varenicline in reducing EDS in PD patients.

PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE MULTIPLE-DOSE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VARENICLINE IN HEALTHY ADOLESCENT SMOKERS

Not approvedWill not start

To characterize the multiple-dose pharmacokinetics of varenicline in adolescent maleand female smoking subjects